UBS Group’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.17M | Sell |
520,905
-405,426
| -44% | -$1.71M | ﹤0.01% | 4895 |
|
|
2025
Q4 | $2.55M | Buy |
926,331
+285,188
| +44% | +$814K | ﹤0.01% | 4728 |
|
|
2025
Q3 | $2.2M | Buy |
641,143
+268,433
| +72% | +$979K | ﹤0.01% | 4850 |
|
|
2025
Q2 | $1.28M | Sell |
372,710
-96,808
| -21% | -$256K | ﹤0.01% | 5227 |
|
|
2025
Q1 | $1M | Sell |
469,518
-102,230
| -18% | -$307K | ﹤0.01% | 5285 |
|
|
2024
Q4 | $1.82M | Buy |
571,748
+485,362
| +562% | +$3.96M | ﹤0.01% | 4808 |
|
|
2024
Q3 | $1.15M | Buy |
86,386
+68,084
| +372% | +$905K | ﹤0.01% | 4531 |
|
|
2024
Q2 | $182K | Buy |
18,302
+17,446
| +2,038% | +$252K | ﹤0.01% | 5723 |
|
|
2024
Q1 | $10.2K | Sell |
856
-965
| -53% | -$8.23K | ﹤0.01% | 7244 |
|
|
2023
Q4 | $7.32K | Buy |
1,821
+1,753
| +2,578% | +$4.93K | ﹤0.01% | 7632 |
|
|
2023
Q3 | $186 | Sell |
68
-16
| -19% | -$75 | ﹤0.01% | 8729 |
|
|
2023
Q2 | $562 | Sell |
84
-416
| -83% | -$2.52K | ﹤0.01% | 8178 |
|
|
2023
Q1 | $3.19K | Sell |
500
-7,930
| -94% | -$32.4K | ﹤0.01% | 8359 |
|
|
2022
Q4 | $21.1K | Buy |
8,430
+8,362
| +12,297% | +$27.5K | ﹤0.01% | 7587 |
|
|
2022
Q3 | $0 | Sell |
68
-1,678
| -96% | -$5.74K | ﹤0.01% | 10367 |
|
|
2022
Q2 | $5K | Buy |
1,746
+1,678
| +2,468% | +$5.13K | ﹤0.01% | 8848 |
|
|
2022
Q1 | $0 | Sell |
68
-12,126
| -99% | -$44.2K | ﹤0.01% | 10297 |
|
|
2021
Q4 | $47K | Buy |
12,194
+7,946
| +187% | +$42.4K | ﹤0.01% | 6958 |
|
|
2021
Q3 | $26K | Buy |
4,248
+4,180
| +6,147% | +$28.5K | ﹤0.01% | 6882 |
|
|
2021
Q2 | $1K | Hold |
68
| – | – | ﹤0.01% | 9129 |
|
|
2021
Q1 | $1K | Sell |
68
-4,915
| -99% | -$74.2K | ﹤0.01% | 8752 |
|
|
2020
Q4 | $22K | Buy |
4,983
+3,813
| +326% | +$16.8K | ﹤0.01% | 6866 |
|
|
2020
Q3 | $7K | Buy |
1,170
+584
| +100% | +$3.81K | ﹤0.01% | 7098 |
|
|
2020
Q2 | $3K | Sell |
586
-3,564
| -86% | -$22.9K | ﹤0.01% | 7526 |
|
|
2020
Q1 | $22K | Buy |
4,150
+3,383
| +441% | +$25.5K | ﹤0.01% | 6429 |
|
|
2019
Q4 | $4K | Buy |
767
+55
| +8% | +$241 | ﹤0.01% | 7648 |
|
|
2019
Q3 | $2K | Buy |
712
+619
| +666% | +$2.24K | ﹤0.01% | 7721 |
|
|
2019
Q2 | $0 | Sell |
93
-2,022
| -96% | -$8.48K | ﹤0.01% | 7872 |
|
|
2019
Q1 | $7K | Buy |
2,115
+1,628
| +334% | +$6.35K | ﹤0.01% | 6996 |
|
|
2018
Q4 | $1K | Sell |
487
-644
| -57% | -$2.76K | ﹤0.01% | 7881 |
|
|
2018
Q3 | $6K | Buy |
1,131
+796
| +238% | +$4.43K | ﹤0.01% | 7396 |
|
|
2018
Q2 | $1K | Sell |
335
-2,011
| -86% | -$9.31K | ﹤0.01% | 7808 |
|
|
2018
Q1 | $10K | Sell |
2,346
-2,058
| -47% | -$9.08K | ﹤0.01% | 6850 |
|
|
2017
Q4 | $17K | Buy |
4,404
+2,651
| +151% | +$12.3K | ﹤0.01% | 6667 |
|
|
2017
Q3 | $9K | Buy |
1,753
+1,685
| +2,478% | +$9.47K | ﹤0.01% | 6941 |
|
|
2017
Q2 | $0 | Hold |
68
| – | – | ﹤0.01% | 7687 |
|
|
2017
Q1 | $0 | Sell |
68
-20
| -23% | -$117 | ﹤0.01% | 7654 |
|
|
2016
Q4 | $1K | Sell |
88
-2,789
| -97% | -$17.1K | ﹤0.01% | 7607 |
|
|
2016
Q3 | $20K | Buy |
2,877
+2,448
| +571% | +$18.6K | ﹤0.01% | 6283 |
|
|
2016
Q2 | $4K | Sell |
429
-296
| -41% | -$2.83K | ﹤0.01% | 7211 |
|
|
2016
Q1 | $7K | Sell |
725
-3,033
| -81% | -$23.9K | ﹤0.01% | 6840 |
|
|
2015
Q4 | $36K | Buy |
3,758
+2,922
| +350% | +$36.4K | ﹤0.01% | 6137 |
|
|
2015
Q3 | $12K | Sell |
836
-876
| -51% | -$12.6K | ﹤0.01% | 7137 |
|
|
2015
Q2 | $25K | Buy |
1,712
+1,644
| +2,418% | +$26.6K | ﹤0.01% | 6656 |
|
|
2015
Q1 | $1K | Buy |
+68
| New | +$1.01K | ﹤0.01% | 8557 |
|
Other funds holding CATX
APM
TCM
CC
OM
VCM
AAA
